Objective: To compare the efficacy and safety of olopatadine and rupatadine in seasonal allergic rhinitis (SAR).
Materials And Methods: A 2-week, single-centered, randomized, open, parallel group comparative clinical study was conducted on patients with SAR. Following inclusion and exclusion criteria, 70 patients were recruited and were randomized to two treatment groups and received the respective drugs for 2 weeks.